The association of the adipokine zinc-alpha2-glycoprotein with non-alcoholic fatty liver disease and related risk factors: A comprehensive systematic review.
Zahra NamkhahFatemeh NaeiniOstadrahimi AlirezaHelda TutunchiMohammad-Javad Hosseinzadeh-AttarPublished in: International journal of clinical practice (2021)
According to the studies reviewed here, ZAG is suggested to be a promising therapeutic target for NAFLD. However, the favourable effects of ZAG need to be confirmed in prospective cohort studies.